Kinnate Biopharma (KNTE) Earnings Date, Estimates & Call Transcripts → Warren Buffett's 'mystery stock' (From Stansberry Research) (Ad) Free KNTE Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSocial MediaSustainability Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueKNTE Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.KNTE Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Wall Street StarThis Apple-like Innovator is Revolutionizing HealthcareAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industry Kinnate Biopharma Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20244($0.41)($0.36)($0.39)Q2 20244($0.42)($0.28)($0.38)Q3 20244($0.43)($0.28)($0.35)Q4 20244($0.44)($0.17)($0.33)FY 202416($1.70)($1.09)($1.44) Get Kinnate Biopharma Earnings AlertsEnter your email address below to receive the latest news and earnings results for KNTE and its competitors with MarketBeat's FREE daily newsletter. Kinnate Biopharma Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript11/9/2023Q3 2023($0.69)($0.65)+$0.04($0.65)--8/8/2023Q2 2023($0.76)($0.68)+$0.08($0.68)--5/11/2023Q1 2023($0.73)($0.73)-($0.73)--3/15/2023Q4 2022($0.70)($0.72)($0.02)($0.72)--11/10/2022Q3 2022($0.60)($0.70)($0.10)($0.70)--8/11/2022Q2 2022($0.65)($0.62)+$0.03($0.62)-- Get the Latest News and Ratings for KNTE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Kinnate Biopharma and its competitors with MarketBeat's FREE daily newsletter. 5/12/2022Q1 2022($0.62)($0.61)+$0.01($0.61)-- 3/28/2022Q4 2021($0.60)($0.60)-($0.60)--11/10/2021Q3 2021($0.53)($0.57)($0.04)($0.57)--8/15/2021Q2 2021($0.43)($0.49)($0.06)($0.49)-- Kinnate Biopharma Earnings - Frequently Asked Questions How much profit does Kinnate Biopharma generate each year? Kinnate Biopharma (NASDAQ:KNTE) has a recorded net income of -$116.27 million. KNTE has generated -$2.78 earnings per share over the last four quarters. What is Kinnate Biopharma's EPS forecast for next year? Kinnate Biopharma's earnings are expected to grow from ($2.51) per share to ($1.25) per share in the next year. More Earnings Resources from MarketBeat Related Companies: LIAN Earnings Results ABEO Earnings Results VTGN Earnings Results IMUX Earnings Results RNAC Earnings Results LIFW Earnings Results KPTI Earnings Results COYA Earnings Results SY Earnings Results NOTV Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Baidu Stock Earnings Prove Ray Dalio Right about China?JD’s Earnings Could Mean Chinese Stocks Making a ComebackHome Depot: Earnings Mixed, Wait to Buy the DipTraders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-Turn This page (NASDAQ:KNTE) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingDoes this make you sick?Allegiance GoldThis Apple-like Innovator is Revolutionizing HealthcareWall Street Star**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge AlertsThis Could be Your “Big Money” AI MomentInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kinnate Biopharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.